Screener
Corpay CPAY Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 43.7%-0.9pp | 46.1%+1.1pp | 44%-0.9pp | 44.5%0.0pp | 44.7%+0.2pp | |
| Net margin | 22.7%-2.4pp | 24.6%-0.6pp | 23.6%-1.6pp | 24.4%-1.8pp | 25.2%-1.2pp | |
| Returns | ||||||
| Return on equity | 30.5%-0.9pp | 33.8%+3.5pp | 30.5%-0.8pp | 29.4%-3.6pp | 31.4%-2.1pp | |
| Return on invested capital | 14.5%+0.1pp | 14.2%+0.2pp | 13.1%-1.0pp | 13.4%-0.8pp | 14.4%-0.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 1×-0.1× | 1×-0.1× | 1×0.0× | 1.1×+0.1× | 1.1×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 3×+0.9× | 3×+0.6× | 2.6×0.0× | 2×-0.5× | 2.1×-0.6× | |
| Net debt / EBITDA | 2.8×+0.2× | 3×-0.1× | 3.2×+0.2× | 2.7×-0.5× | 2.7×-0.3× | |
| Per Share | ||||||
| Book value per share | $53.40-2.9% | $51.29+6.3% | $54.66+25.8% | $57.30+31.6% | $55.00+43.0% | |
| Valuation | ||||||
| Market capitalization | $26.4B+28.5% | $19.8B-19.2% | $21.05B-10.8% | $20.34B-7.2% | $23.23B+21.5% | |
| Price / earnings | 23.1×+3.6× | 16.8×-7.3× | 19.7×-3.8× | 19.3×-2.3× | 22.1×+3.2× | |
| Price / sales | 5.3×+0.5× | 4.1×-1.9× | 4.6×-1.3× | 4.7×-0.9× | 5.6×+0.6× | |
| Price / book | 7.5×+2.4× | 5.6×-1.5× | 5.4×-2.1× | 5×-2.1× | 5.9×-1.0× | |
| EV / EBITDA | 12.8×+1.2× | 10.5×-3.8× | 12×-2.0× | 11.6×-2.2× | 13.1×+0.8× |
FAQ
- Where do Corpay's ratios come from?
- Every ratio is computed from Corpay's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
